Botanix Pharmaceuticals Ltd. of NORTH PERTH, WESTERN AUSTRALIA, C3, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-14. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Pharmaceuticals.
| Name | Role | Location |
|---|---|---|
| William Bosch | Director | Plymouth Meeting, PA |
| Matthew Callahan | Director | Plymouth Meeting, PA |
| Vince Ippolito | Director | San Diego, CA |
| Michael Thurn | Director | Plymouth Meeting, PA |
| Robert Towner | Director | Plymouth Meeting, PA |
| Stewart Washer | Director | Plymouth Meeting, PA |
| William Bosch | Executive Officer | Plymouth Meeting, PA |
| Matthew Callahan | Executive Officer | Plymouth Meeting, PA |
| Vince Ippolito | Executive Officer | San Diego, CA |
| Stephane Levy | Executive Officer | Plymouth Meeting, PA |
| Howie McKibbon | Executive Officer | Plymouth Meeting, PA |
| Ric Peterson | Executive Officer | Plymouth Meeting, PA |
| Michael Thurn | Executive Officer | Plymouth Meeting, PA |